Panel Probes FDA Moves On Antidepressant Risks

A U.S. House of Representatives committee is investigating whether health officials issued timely warnings about a potential suicide risk in children treated with antidepressants, two leading Republicans said on Wednesday.

MORE ON THIS TOPIC